381 related articles for article (PubMed ID: 22846185)
1. Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia.
Liew A; O'Brien T
Stem Cell Res Ther; 2012 Jul; 3(4):28. PubMed ID: 22846185
[TBL] [Abstract][Full Text] [Related]
2. Self-assembled GFFYK peptide hydrogel enhances the therapeutic efficacy of mesenchymal stem cells in a mouse hindlimb ischemia model.
Huang A; Liu D; Qi X; Yue Z; Cao H; Zhang K; Lei X; Wang Y; Kong D; Gao J; Li Z; Liu N; Wang Y
Acta Biomater; 2019 Feb; 85():94-105. PubMed ID: 30550934
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of mouse bone marrow and adipose tissue mesenchymal stem cells for critical limb ischemia cell therapy.
Nammian P; Asadi-Yousefabad SL; Daneshi S; Sheikhha MH; Tabei SMB; Razban V
Stem Cell Res Ther; 2021 Jan; 12(1):58. PubMed ID: 33436054
[TBL] [Abstract][Full Text] [Related]
4. Emerging roles of mesenchymal stem cell therapy in patients with critical limb ischemia.
Shirbaghaee Z; Hassani M; Heidari Keshel S; Soleimani M
Stem Cell Res Ther; 2022 Sep; 13(1):462. PubMed ID: 36068595
[TBL] [Abstract][Full Text] [Related]
5. Report of a phase 1 clinical trial for safety assessment of human placental mesenchymal stem cells therapy in patients with critical limb ischemia (CLI).
Shirbaghaee Z; Heidari Keshel S; Rasouli M; Valizadeh M; Hashemi Nazari SS; Hassani M; Soleimani M
Stem Cell Res Ther; 2023 Jul; 14(1):174. PubMed ID: 37408043
[TBL] [Abstract][Full Text] [Related]
6. Molecular Imaging of Therapeutic Effect of Mesenchymal Stem Cell-Derived Exosomes for Hindlimb Ischemia Treatment.
Zhang K; Li Z
Methods Mol Biol; 2020; 2150():213-225. PubMed ID: 30941719
[TBL] [Abstract][Full Text] [Related]
7. Plasminogen regulates mesenchymal stem cell-mediated tissue repair after ischemia through Cyr61 activation.
Duan H; He Z; Lin M; Wang Y; Yang F; Mitteer RA; Kim HJ; Yeo E; Han H; Qin L; Fan Y; Gong Y
JCI Insight; 2020 Aug; 5(15):. PubMed ID: 32759492
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic injection of fetal membrane-derived mesenchymal stem cells induces therapeutic angiogenesis in a rat model of hind limb ischemia.
Ishikane S; Ohnishi S; Yamahara K; Sada M; Harada K; Mishima K; Iwasaki K; Fujiwara M; Kitamura S; Nagaya N; Ikeda T
Stem Cells; 2008 Oct; 26(10):2625-33. PubMed ID: 18669910
[TBL] [Abstract][Full Text] [Related]
9. Neovascularization capacity of mesenchymal stromal cells from critical limb ischemia patients is equivalent to healthy controls.
Gremmels H; Teraa M; Quax PH; den Ouden K; Fledderus JO; Verhaar MC
Mol Ther; 2014 Nov; 22(11):1960-70. PubMed ID: 25174586
[TBL] [Abstract][Full Text] [Related]
10. Human Umbilical Cord-Derived Mesenchymal Stem Cells Relieve Hind Limb Ischemia by Promoting Angiogenesis in Mice.
Wang Z; Zheng L; Lian C; Qi Y; Li W; Wang S
Stem Cells Dev; 2019 Oct; 28(20):1384-1397. PubMed ID: 31407635
[TBL] [Abstract][Full Text] [Related]
11. Comparison of angiogenic potency between mesenchymal stem cells and mononuclear cells in a rat model of hindlimb ischemia.
Iwase T; Nagaya N; Fujii T; Itoh T; Murakami S; Matsumoto T; Kangawa K; Kitamura S
Cardiovasc Res; 2005 Jun; 66(3):543-51. PubMed ID: 15914119
[TBL] [Abstract][Full Text] [Related]
12. PEP-1-CAT-transduced mesenchymal stem cells acquire an enhanced viability and promote ischemia-induced angiogenesis.
Zhang L; Dong XW; Wang JN; Tang JM; Yang JY; Guo LY; Zheng F; Kong X; Huang YZ; Chen SY
PLoS One; 2012; 7(12):e52537. PubMed ID: 23285080
[TBL] [Abstract][Full Text] [Related]
13. Concise Review: Cell Therapy for Critical Limb Ischemia: An Integrated Review of Preclinical and Clinical Studies.
Qadura M; Terenzi DC; Verma S; Al-Omran M; Hess DA
Stem Cells; 2018 Feb; 36(2):161-171. PubMed ID: 29226477
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cell therapy for ischemic stroke: A look into treatment mechanism and therapeutic potential.
Li J; Zhang Q; Wang W; Lin F; Wang S; Zhao J
J Neurol; 2021 Nov; 268(11):4095-4107. PubMed ID: 32761505
[TBL] [Abstract][Full Text] [Related]
15. In vivo efficacy of endothelial growth medium stimulated mesenchymal stem cells derived from patients with critical limb ischemia.
Al-Rifai R; Nguyen P; Bouland N; Terryn C; Kanagaratnam L; Poitevin G; François C; Boisson-Vidal C; Sevestre MA; Tournois C
J Transl Med; 2019 Aug; 17(1):261. PubMed ID: 31399109
[TBL] [Abstract][Full Text] [Related]
16. Mammalian MSC from selected species: Features and applications.
Uder C; Brückner S; Winkler S; Tautenhahn HM; Christ B
Cytometry A; 2018 Jan; 93(1):32-49. PubMed ID: 28906582
[TBL] [Abstract][Full Text] [Related]
17. Concise Review: Rational Use of Mesenchymal Stem Cells in the Treatment of Ischemic Heart Disease.
Ward MR; Abadeh A; Connelly KA
Stem Cells Transl Med; 2018 Jul; 7(7):543-550. PubMed ID: 29665255
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of angiogenic effects by hypoxia-preconditioned human umbilical cord-derived mesenchymal stem cells in a mouse model of hindlimb ischemia.
Han KH; Kim AK; Kim MH; Kim DH; Go HN; Kim DI
Cell Biol Int; 2016 Jan; 40(1):27-35. PubMed ID: 26222206
[TBL] [Abstract][Full Text] [Related]
19. Regenerative Potential of the Product "CardioCell" Derived from the Wharton's Jelly Mesenchymal Stem Cells for Treating Hindlimb Ischemia.
Musiał-Wysocka A; Kot M; Sułkowski M; Majka M
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540534
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic Mesenchymal Stromal Cells (MSCs) are of Comparable Efficacy to Syngeneic MSCs for Therapeutic Revascularization in C57BKSdb/db Mice Despite the Induction of Alloantibody.
Liew A; Baustian C; Thomas D; Vaughan E; Sanz-Nogués C; Creane M; Chen X; Alagesan S; Owens P; Horan J; Dockery P; Griffin MD; Duffy A; O'Brien T
Cell Transplant; 2018 Aug; 27(8):1210-1221. PubMed ID: 30016879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
